Lexpos News

/Lexpos News

Medicine Supply Notification: Epilim® (sodium valproate) syrup 200mg/5ml

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Epilim® (sodium valproate) syrup 200mg/5ml MSN/2024/023 Tier 2 – medium impact Date of issue: 21st February 2024 Epilim® 200mg/5ml syrup is out of stock from mid-March until w/c 22nd April 2024. Epilim® (sodium valproate) 200mg/5ml liquid (sugar-free) remains available and can [...]

The post Medicine Supply Notification: Epilim® (sodium valproate) syrup 200mg/5ml appeared first on Community Pharmacy England.

By |February 21st, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Epilim® (sodium valproate) syrup 200mg/5ml

Pharmacy First: NHSE campaign materials now available

Following the launch of NHS England’s (NHSE) ‘Think Pharmacy first’ campaign on Monday (19th February),  campaign materials are now available for pharmacy teams to use. The campaign materials are available on the Department of Health and Social Care’s Campaign Resource Centre website and include: A campaign toolkit; Social assets; and Posters. View the ‘Think Pharmacy [...]

The post Pharmacy First: NHSE campaign materials now available appeared first on Community Pharmacy England.

By |February 21st, 2024|Lexpos News|Comments Off on Pharmacy First: NHSE campaign materials now available

Verifying your NHS Profile Manager profile

Ahead of the 31st March 2024 deadline, we would like to remind pharmacy owners of the need to update NHS Profile Manager to ensure that their pharmacy’s NHS website and Directory of Service (DoS) profile information is up to date. The NHS Terms of Service require pharmacy owners to check that their opening hours, contact [...]

The post Verifying your NHS Profile Manager profile appeared first on Community Pharmacy England.

By |February 21st, 2024|Lexpos News|Comments Off on Verifying your NHS Profile Manager profile

MHRA Drug Safety Update: February 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 7 February 2024) has been published and includes articles on: Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) Letters and medicine recalls sent [...]

The post MHRA Drug Safety Update: February 2024 appeared first on Community Pharmacy England.

By |February 20th, 2024|drug safety, Lexpos News, mhra, safety|Comments Off on MHRA Drug Safety Update: February 2024

Medicines supply will fail if pharmacies cannot keep lights on, warns Community Pharmacy England

Patients will continue to face problems accessing medicines unless Government both eases supply problems in the UK, and resolves the critical financial state of community pharmacies, Community Pharmacy England has warned. Janet Morrison, CEO, and Mike Dent, Director of Pharmacy Funding, both gave evidence to the Health and Social Care Select Committee on Monday 19th [...]

The post Medicines supply will fail if pharmacies cannot keep lights on, warns Community Pharmacy England appeared first on Community Pharmacy England.

By |February 19th, 2024|Lexpos News|Comments Off on Medicines supply will fail if pharmacies cannot keep lights on, warns Community Pharmacy England